Inventor
SEHGAL ALFICA
US20 patents
⚠️ This page may combine multiple inventors who share the name “SEHGAL ALFICA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALNYLAM PHARMACEUTICALS INC
13 patentsUS9574192B2Feb 21, 2017
Serapina1 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC14 citations92
US11504391B1Nov 22, 2022
Modified RNA agents with reduced off-target effect
ALNYLAM PHARMACEUTICALS INC18 citations84
US10030244B2Jul 24, 2018
Serpina1 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC6 citations84
US9879261B2Jan 30, 2018
Serpina1 siRNAs: compositions of matter and methods of treatment
ALNYLAM PHARMACEUTICALS INC10 citations84
US9376680B2Jun 28, 2016
Serpinc1 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC7 citations84
US10995336B2May 4, 2021
Serpina1 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC8 citations83
US10935917B2Mar 2, 2021
Serpina1 siRNAs: compositions of matter and methods of treatment
ALNYLAM PHARMACEUTICALS INC2 citations73
US10920223B2Feb 16, 2021
Serpina1 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC2 citations73
US10683504B2Jun 16, 2020
Serpina1 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC2 citations73
US10077444B2Sep 18, 2018
Compositions and methods for inhibiting expression of the LECT2 gene
ALNYLAM PHARMACEUTICALS INC2 citations73
US12071619B2Aug 27, 2024
SERPINA1 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC0 citations62
US11725207B2Aug 15, 2023
Serpina1 iRNA compositions and methods of use thereof
ALNYLAM PHARMACEUTICALS INC1 citations62
US10669303B2Jun 2, 2020
Compositions and methods directed to treating liver fibrosis
ALNYLAM PHARMACEUTICALS INC0 citations52
CAMP4 THERAPEUTICS CORP
4 patentsUS11542290B2Jan 3, 2023
Phenothiazine derivatives and uses thereof
CAMP4 THERAPEUTICS CORP2 citations70
US12145963B2Nov 19, 2024
Phenothiazine derivatives and uses thereof
CAMP4 THERAPEUTICS CORP0 citations59
US11266655B2Mar 8, 2022
Methods and compositions for treating urea cycle disorders
CAMP4 THERAPEUTICS CORP1 citations51
US12319916B2Jun 3, 2025
Modulation of gene transcription using antisense oligonucleotides targeting regulatory RNAs
CAMP4 THERAPEUTICS CORP0 citations50